Project Grant R21MH134061

Award Date 5/15/24
Completion Date 5/14/26
Dollars Obligated $481K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This Project Grant award of $246,000.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to reverse-translate discoveries from post-mortem human brain analyses to study the role of the dentate gyrus (DG) region of the hippocampus in the pathophysiology of psychosis. The key objectives are to: (i) investigate how gradual suppression of DG activity triggers hyper-synchronous events in the hippocampus, and (ii) examine how...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $429,000.00 in funding to Thomas Jefferson University to conduct research on cell-type specific analysis of Src kinase-NMDA receptor complexes in schizophrenia. The goal of this 2-year project is to determine how Src kinase-mediated NMDA receptor signaling alterations are distinctly manifested in pyramidal neurons versus interneurons in the...
This $2,694,945 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) funds research to identify cellular phenotypes related to the etiology, pathophysiology, and symptomatology of schizophrenia. The primary objectives are to: 1) replicate and expand on prior findings linking electrophysiological variables in patient-derived induced pluripotent stem cell (iPSC) models to clinical and cognitive phenotypes of...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support research to determine the relationship between the neurotransmitter N-acetyl-aspartyl-glutamate (NAAG) and memory deficits in schizophrenia patients in mid- to late-life. The $804,690 award to The Johns Hopkins University will fund a 5-year study to measure NAAG levels in schizophrenia patients and healthy adults, and correlate these levels...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $811,404 to The Trustees of Columbia University in the City of New York to conduct research on the neural circuit mechanisms underlying anticipatory anhedonia in schizophrenia. The goal of this research is to utilize a computational psychiatry approach to dissect the neural circuitry responsible for altered reward anticipation in individuals with...
The National Institute of Mental Health (NIMH) awarded a $1,491,482 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. The grant, titled "Using Neuroimaging to Investigate Mechanism-Based Biomarkers of Schizophrenia," aims to investigate the neurobiological correlates of increased extracellular water volume (free water) observed in schizophrenia patients. The research will utilize a validated animal model to characterize the...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants supports research to understand the neurobiological basis of schizophrenia and its impact on hippocampal network dynamics and spatial memory. The $231,547 award to George Mason University, a prominent research university, aims to investigate how NMDA receptor signaling regulates hippocampal oscillations and spatial memory retrieval. The study uses transgenic...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $388,800 to The Trustees of Columbia University in the City of New York to conduct research on the genetic links between autism spectrum disorder (ASD) and schizophrenia (SCZ). The goal is to evaluate cognitive functioning and psychopathology in autistic individuals who carry genetic variants associated with both ASD and SCZ. The research will...
This $735,932 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to elucidate the cellular mechanisms underlying positive symptoms in mouse models of schizophrenia (SCZ) genetic risk factors. The award, with a period of performance from April 2025 to January 2030, will be administered by St. Jude Children's Research Hospital. The key focus is to characterize disruptions in thalamocortical (TC) projections...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $625,108 to the University of California, Irvine (UC Irvine) to conduct research on the cellular and circuit mechanisms underlying associative memory formation in the lateral entorhinal cortex (LEC). The key objectives are to: 1) Identify the roles of serotonin inputs to LEC layer 5/6 neurons in associative learning; 2) Determine the functions of...

MAPPING RELATIONAL MEMORY DEFICITS AND THEIR HIPPOCAMPAL CORRELATES IN SCHIZOPHRENIA - ABSTRACT (PROJECT SUMMARY) DESPITE DECADES OF RESEARCH, SCHIZOPHRENIA REMAINS THE MOST DEVASTATING OF ALL PSYCHIATRIC DISORDERS. SCHIZOPHRENIA IS CHARACTERIZED BY SIGNIFICANT DEFICITS IN NEURAL AND COGNITIVE PROCESSING, SHORTENED LIFESPANS, AND TREMENDOUS SOCIAL, PERSONAL, AND ECONOMIC BURDEN-FOR PATIENTS, THEIR FAMILIES, AND SOCIETY. THE DEVELOPMENT OF COGNITIVE MARKERS THAT CAN TRACK CLINICAL AND NEURAL PROGRESSION IS A PROMISING AVENUE FOR MONITORING ILLNESS BURDEN AND EFFECTIVE TREATMENT RESPONSE. YET, DESPITE ENTHUSIASM FOR COGNITIVE MARKERS OF PROGRESSION, CLINICALLY USEFUL MARKERS HAVE PROVEN DIFFICULT TO IDENTIFY. ONE REASON FOR THIS MAY BE THE LACK OF FIDELITY BETWEEN POTENTIAL COGNITIVE MARKERS AND NEUROPATHOLOGY. COGNITIVE MARKERS THAT ARE CAUSALLY LINKED WITH BRAIN PATHOLOGY ARE NEEDED TO OVERCOME THIS OBSTACLE. WE PROPOSE THAT RELATIONAL MEMORY - A FORM OF MEMORY DEPENDENT ON THE HIPPOCAMPUS - IS IDEALLY SUITED AS A MARKER OF NEUROPATHOLOGY IN SCHIZOPHRENIA. HIPPOCAMPAL ATROPHY IS ONE OF THE MOST SIGNIFICANT BRAIN ABNORMALITIES IN CHRONIC SCHIZOPHRENIA BUT IS LESS PRONOUNCED IN THE PRODROMAL AND EARLY STAGE OF PSYCHOSIS. PROGRESSIVE MICROSTRUCTURAL CHANGES, RESULTING FROM AN EXCITATION/INHIBITION IMBALANCE ADVANCING FROM THE HIPPOCAMPAL HEAD TO ENCOMPASS THE HIPPOCAMPAL BODY AND TAIL HAS BEEN IDENTIFIED AS A PLAUSIBLE MECHANISM FOR THE HIPPOCAMPAL ATROPHY OBSERVED OVER ILLNESS STAGES IN SCHIZOPHRENIA. WE PROPOSE TO USE A NOVEL PARADIGM DEVELOPED AND VALIDATED IN HIPPOCAMPAL AMNESIA PATIENTS TO QUANTIFY PERFORMANCE ACROSS THREE TYPES OF RELATIONAL MEMORY - ASSOCIATIVE, TEMPORAL, AND SPATIAL - IN SCHIZOPHRENIA. AS DISTINCT RELATIONAL MEMORY TYPES HAVE BEEN SHOWN TO SEGREGATE ALONG THE HIPPOCAMPAL LONGITUDINAL AXIS, WE PROPOSE THAT IMPAIRMENT WITHIN RELATIONAL MEMORY TYPES WILL MAP TO DYSFUNCTION IN DISTINCT HIPPOCAMPAL DIVISIONS OF THE HEAD (ASSOCIATIVE MEMORY), BODY (TEMPORAL MEMORY), AND TAIL (SPATIAL MEMORY). FURTHER, WE WILL TEST THE RELATIONSHIP BETWEEN RELATIONAL MEMORY IMPAIRMENTS AND HIPPOCAMPAL PATHOLOGY OVER ILLNESS STAGES. TO TEST OUR HYPOTHESES, WE WILL EXAMINE HIPPOCAMPAL VOLUME AND MICROSTRUCTURE IN PATIENTS RANGING FROM EARLY TO CHRONIC ILLNESS STAGES. THE PROPOSED COMBINATION OF A MULTI- TYPE, HIPPOCAMPAL-DEPENDENT RELATIONAL MEMORY ASSESSMENT WITH MULTI-DIMENSIONAL HIPPOCAMPAL NEUROIMAGING WILL ALLOW US TO CHARACTERIZE THE RELATIONSHIP BETWEEN RELATIONAL MEMORY FUNCTION AND HIPPOCAMPAL STRUCTURAL ABNORMALITIES. THE ESTABLISHMENT OF A COGNITIVE MARKER SENSITIVE TO HIPPOCAMPAL STRUCTURE WILL SIGNIFICANTLY IMPROVE OUR ABILITY TO TRACK, INTERVENE, AND PREVENT THE PROGRESSION FROM EARLY PSYCHOSIS TO SCHIZOPHRENIA.

Posted 5/10/24, 12:00 AM